Kyowa Hakko USA “brought immune and cognitive health to life” for attendees of the SupplySide West trade show earlier this month. The health ingredient manufacturer featured its IMMUSE postbiotic and Cognizin citicoline branded ingredients in educational and interactive outreach during the show.
IMMUSE postbiotic is a clinically researched immune activator supported by nearly 30 published studies, including 14 human trials. IMMUSE delivers a breakthrough approach to comprehensive immune support through a novel method of action that utilizes a rare but key type of immune cells called plasmacytoid dendritic cells (pDC), which have been shown to activate cells that are pivotal to immune support, such as NK, Killer-T, Helper-T, and B cells.
Heather Moday, MD, author of "The Immunotype Breakthrough," spoke at SupplySide West and assisted members of the audience in determining their personal immunotypes. Moday explained how immunotypes can be used to identify individuals’ most effective methods of immune support and how IMMUSE’s unique mode of action can support that process – a mode of action that was discovered by Kyowa Hakko's parent company Kirin Holdings.
“Our body registers all stressors, including work, financial, and family stress just to name a few, in the same way as a real physical threat,” said Moday during her presentation. “When you add up all of the small stressors that are constantly triggering our fight-or-flight response, it leads to changes in our immune system.”
We had the same positive response at SupplySide West, and we were excited to bring the benefits of Cognizin to life
Cognizin, Kyowa Hakko’s branded form of citicoline, is a potent brain health nutrient and nootropic that has been shown through extensive clinical studies and human trials to support mental energy, focus, memory, and attention. While many other cognitive health ingredients only enhance brain
performance, citicoline increases an important substance in the brain called phosphatidylcholine that offers multifaceted benefits. Cognizin is an innovative, pure form of citicoline.
At SupplySide West, Kyowa Hakko emulated a clinical study that targeted e-gamers and was conducted by neuropsychologists using a variety of tests simulating cognitive functions and keyboard actions, including a finger tap test. Tradeshow attendees could participate in the “Tap Challenge,” available through an app, to see how quickly they could tap a button over a 20-second timeframe.
“We debuted this app at SxSW and it was a hit,” said Karen Todd, MBA, RD, Vice President Global Brand Marketing, Kyowa Hakko USA. “We had the same positive response at SupplySide West, and we were excited to bring the benefits of Cognizin to life for the researchers and innovators behind the next big nutraceuticals and functional foods and beverages.”
